Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» narsoplimab
narsoplimab
Omeros terminates kidney disease trial as therapy fails in late-stage study
Reuters
Mon, 10/16/23 - 10:15 am
Omeros
kidney disease
clinical trials
narsoplimab
Berger's disease
After rejection and appeal, Omeros saddles up for 2nd charge at transplant drug approval
BioSpace
Tue, 03/14/23 - 10:59 am
Omeros
transplant-associated thrombotic microangiopathy
organ transplants
narsoplimab
Omeros' Hail Mary throw for blood clot med application delayed at FDA
Fierce Biotech
Wed, 08/17/22 - 12:12 pm
Omeros
FDA
narsoplimab
Omeros Reports Coronavirus Treatment Success; Stock Soars
Investors Business Daily
Mon, 08/10/20 - 10:58 am
Omeros
clinical trials
COVID-19
narsoplimab
Omeros hits endpoint in pivotal stem cell transplant study
Fierce Biotech
Wed, 12/4/19 - 09:58 am
Omeros
narsoplimab
stem cells
stem cell transplant
clinical trials